Posts by Tiara Calhoun, MD
-
Study of Interferon + Antivirals in COVID-19 Is First Published Randomized Trial with Positive Results
Massachusetts General Hospital Researchers find that early triple therapy with interferon beta-1b, lopinavir–ritonavir and ribavirin was safe and superior to lopinavir–ritonavir alone in shortening virus shedding, alleviating symptoms, and facilitating discharge of patients with mild to moderate COVID-19.
-
Neutralizing SARS-CoV-2-specific Antibodies and Virus-Specific T Cells Detected in People Recovering from COVID-19
Massachusetts General Hospital reserarchers discuss a new study that provides the most comprehensive evidence yet that people who recover from COVID-19 acquire protective immunity.
-
New Data on Protective Immunity After COVID-19
The world is eager for an “immunity test” for SARS-CoV-2, but the level and duration of protective immunity after recovery from COVID-19 remain to be defined.
-
Effects of COVID-19 on Pregnant Women and Neonates
Physicians at Massachusetts General Hospital report that management of critically ill pregnant patients with COVID-19 should not differ significantly from standard critical care.
-
Pregnancy and SARS-CoV-2 infection
Many people are worrying...that pregnant women are more likely to have poor outcomes from SARS-CoV-2 infection.
-
Post-extubation Stridor in COVID-19
Many people are saying...COVID-19 patients experience post-extubation stridor.
-
Inhaled Nitric Oxide Preferred to Epoprostenol in COVID-19 as Rescue Therapy
Despite frequent use in patients with acute respiratory distress syndrome, inhaled pulmonary vasodilators have never been shown to improve survival.
-
COVID-19 Risk Factor Round-Up
Many people are saying...with regards to risk factors for severe COVID-19, [it’s] the same as it ever was...
-
iNO in COVID-19
Tonight's FLARE will discuss the use of inhaled pulmonary vasodilators in ARDS, with a focus on the potential role of inhaled nitric oxide in COVID-19.
-
FAQs, GI Disease, Washington and Italy
This FLARE will cover FAQs about the Mass General Critical Care Guidance, COVID-19 presenting as GI disease and analysis of newly published clinical data.
